Fractal Analytics reported a significant financial leap, with its Q4 profit after tax doubling to Rs 116 crore, fueled by an impressive 82% surge in its healthcare and life sciences division. The company’s overall revenue also saw a healthy 17% increase. This robust performance, coupled with a debt-free status post-IPO, positions Fractal for continued expansion.
Dr Reddy’s Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announced
Dr Reddy’s Laboratories Q4 Results: Dr. Reddy’s Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter versus Rs 1,587 crore